Cytogenetic monoclonality in multifocal uroepithelial carcinomas: Evidence of intraluminal tumour seeding

British Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 6-12

  Fadl Elmula, I ^a,b   Gorunova, L ^a   Mandahl, N ^a   Elfving, P ^a   Lundgren, R ^b   Mitelman, F ^a   Heim, S ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytogenetics; Intraluminal seeding; Monoclonality; Multifocal uroepithelial carcinomas

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CELL VIABILITY; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR CELL CULTURE; URINARY TRACT CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME BANDING; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; NEOPLASM SEEDING; NEOPLASM STAGING; TUMOR CELLS, CULTURED; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0032849741     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690643     Document Type: Article

References (39)

1. Badalament RA and Schervish EW (1996) Bladder cancer, current diagnostic methods and treatment options. Postgrad Med 100: 217-230
2. Breul J, Block T, Breidenbach H and Hartung R (1992) Implantation metastasis after a suprapubic catheter in a case of bladder cancer. Eur Urol 22: 86-88
3. Chern HD, Becich MJ, Persad RA, Romkes M, Smith P, Collins C, Li YH and Branch RA (1996) Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins, J Urol 156: 1846-1849
4. Fadl-Elmula I, Gorunova L, Lundgren R, Mandahl N, Forsby N, Mitelman F and Heim S (1998) Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation. Cancer Genet Cytogenet 102: 125-130
5. Fitzpatrick JM, West AB and Butler MR (1986) Superficial bladder tumors (stage pTa grade 1 and 2). The importance of recurrence pattern following initial resection. J Urol 135: 920-922
6. Fujimoto K, Yamada Y. Okajima E, Kakizoe T, Sasaki H, Sugimura T and Terada M (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 52: 1393-1398
7. Garden RJ, Liu BC and Redwood SM (1992) Bacillus Calmette Guerin (BCG) abrogates in vitro invasion and motility of human bladder tumor cell via fibronectin interactions. J Urol 148: 900-950
8. Gibas Z and Gibas L (1997) Cytogenetics of bladder cancer. Cancer Genet Cytogenet 95: 108-115
9. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D. Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG and Cote RJ (1997) Thrombospondin-1 expression in bladder cancer: association with TP53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89: 219-227
10. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T and Yoshida O (1993) Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342: 1087-1088
11. Harris AL and Neal DE (1992) Bladder cancer, field versus clonal origin. N Engl J Med 326: 759-761
12. Heim S (1992) Is cancer cytogenetics reducible to the molecular genetics of cancer cells? Genes Chromosomes Cancer 5; 188-196
13. Heney NM, Proppe K, Prout GR, Griffin PP and Shipley WU (1983) Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 130: 895-902
14. Heney NM, Ahmed S and Flanagan MJ (1983) Superficial bladder cancer. Progression and recurrence. J Urol 130: 1083-1086
15. Herr HW (1997) Natural history of superficial bladder cancer: 10-to 20-year follow-up of treated patients. World J Urol 15: 84-88
16. TSCN (1995) An International System for Human Cytogenetic Nomenclature. Mitelman F (ed.). S Karger: Baset
17. Kakizoe T, Fujita J, Murase T, Matsumotoko K and Kishi K (1980) Transitional cell carcinoma of the bladder in patients with renal pelvis and ureteral cancer. J Urol 124: 17-19
18. Kenworthy P, Tanguay S and Dinney CP (1996) The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 155: 501-504
19. Kiemeney LA, Witjes JA, Heijbrock RP, Koper NP, Verbeek AI, and Debruyne FM (1993) Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150: 60-64
20. Lynch CF and Cohen MB (1995) Urinary system. Cancer 75: 316-345
21. Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V and Koeffler HP (1986) Human TP53 gene localized to short arm of chromosome 17. Nature 319: 783-784
22. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruk CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG and Jones PA (1993) Role of chromosome 9 in human bladder cancer. Cancer Res 53: 4066-4070
23. Morton RA, Ewing CM, Watkins JJ and Isaac WB (1995) The E-cadherin cell adhesion pathway in urologic malignancies. World J Urol 13: 364-372
24. Nicol D (1995) BCG in bladder cancer: a warning. Aust NZ J Med 25: 275-282
25. Parker SL, Tong T, Bolden S and Wingo PA (1996) Cancer statistics. Ca Cancer J Clin 46: 5-27
26. Prout GR, Barton, Griffin PP and Friedell GH (1992) Trealed history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Group. J Urol 148: 1413-1419
27. Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Blelloch RH, Puthenveettil JA and Cuthill SA (1996) Molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 23: 571-584
28. Richie JP, Shipley WU and Yagoda A (1989) Cancer of the bladder. In: Cancer Principles and Practice of Oncology, De Vita VT, Helman S and Rosenberg SA (eds), pp. 1008-1022. JB Lippincett: Philadelphia
29. Rosin MP, Anwar WA and Ward AJ (1994) Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 54: 1929-1933
30. Schmitz-Dräger BJ, Jankevicius F and Ackermann R (1996). Molecular biology of dissemination in bladder cancer laboratory findings and clinical significance. World J Urol 14: 190-196
31. Sidransky D, Frost P, Von-Eschenbach A, Oyasu R, Preisinger AC and Vogelstein B (1992) Clonal origin of bladder cancer. N Eng J Med 326: 737-740
32. Thompson RA, Campbell EW, Kramer HC, Jacobs SC and Naslund MJ (1993) Late invasive recurrence despite long-term survival for superficial bladder cancer. J Urol 149: 1010-1011
33. Union International Contre le Cancer (1978) TNM Classification of Malignant Tumors. Union International Contre le Cancer, Geneva
34. Unyime ON and Donald LL (1994) Therapy of superficial cancer. Curr Opin Urol 4: 275-280
35. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA (1995) P10 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577
36. Wolf H and Hojgaard K (1982) Urothelial dysplasia concomitant with bladder tumors as a determinant factor for future new occurrences. Lancet 2: 134-140
37. World Health Organization (1973) Histological Typing of Urinary Bladder Tumors. International Histological Classification of Tumors: Geneva
38. Xu X, Stower MJ, Reid NI and Garner RC (1996) Burns PA Molecular screening of multifocal transitional cell carcinomas of the bladder using TP53 mutations as biomarkers. Clin Cancer Res 2: 1795-1800
39. Yao A and Rubin HA (1994) Critical test of the role of population density in producing transformation. Proc Natl Acad Sci USA 91: 7712-7716